Clinical year in review

Clinical year in review - hero image

Taken from the ERS Congress pre-event programme, this year in review provides an overview of the most relevant advances in diagnosis and treatment of some of the most prevalent respiratory diseases, and presents the most important studies published in the last 12 months about clinical aspects of COVID-19, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.

You can still register for the ERS International Congress and have access to ALL sessions from the event until the end of December.


COPD: Implementing biomarkers to improve prognosis

Duration: 15:00

Speaker: Miriam Barrecheguren

 


Early COVID-19 treatments and what it means for respiratory patients

Duration: 16:00

Speaker: Mona Bafadhel

 


Severe asthma: Classification and treatment

Duration: 15:30

Speaker: Guy Brusselle

 


Interstitial lung disease: Improving classification and prognosis

Duration: 16:00

Speaker: Luca Richeldi

 


ERS Congress 2021

Relive the ERS Congress 2021

ERS International Congress 2021 delegates can access all content and session recordings at any time until the end of December 2021. If you did not take part, you can still register to access this content.

Access the platform / register